Monitor HIFU revenue execution against 2026 guidance; assess whether growing system placements and procedures can offset continued non-core business decline and improve profitability. Watch cash burn and potential need for financing.
Price Chart
Executive Summary
EDAP reported record full-year 2025 HIFU revenue with 39% YoY growth, driven by strong Focal One system sales and a 28% increase in U.S. procedures. However, total company revenue declined 3% YoY due to a significant drop in non-core ESWL and distribution businesses. The company posted a wider net loss of $29.2 million and reduced cash reserves, though it reiterated strong 2026 HIFU revenue growth guidance of 34%-45%.
Key Financial Metrics
Key Facts
- HIFU revenue grew 39% YoY to $37.4 million in 2025, with 69% growth in Focal One system placements
- Total company revenue declined 3% YoY to $70.5 million due to 27% drop in non-core ESWL and distribution revenue
- Net loss widened to $29.2 million in 2025 from $20.6 million in 2024
- Cash and equivalents dropped 31% YoY to $20.5 million
- Gross margin improved to 42.5% despite tariff impacts and inventory reserves
- Company reiterated 2026 HIFU revenue guidance of $50M–$54M, representing 34%–45% YoY growth
Financial Impact
HIFU segment growing strongly at 39% YoY, but overall revenue declining and losses widening; cash burn of $16.4M in operating activities
Risk Factors
- Continued decline in non-core businesses may pressure overall revenue and cash flow
- Widening net losses and declining cash reserves raise sustainability concerns
- Execution risk in maintaining HIFU growth momentum and achieving 2026 guidance
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3262097 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 17, 2026 6w ago | Insider Cluster | — | awaiting T+20 | — | — |
May 29, 2026 18w ago | 8-K | $4.32 $5.10 | ▲ +18.06% | ▲ +19.85% | — |
May 14, 2026 20w ago | DEFA14A | $4.13 $4.77 | ▼ −15.50% | ▼ −16.35% | — |
May 14, 2026 20w ago | DEFA14A | $4.13 $4.77 | ▲ +15.50% | ▲ +16.35% | — |
May 14, 2026 20w ago | Press Release | $4.13 $4.77 | ▲ +15.50% | ▲ +16.35% | — |
May 7, 2026 21w ago | 8-K | $4.16 $4.69 | ▲ +12.74% | ▲ +9.60% | — |
Apr 16, 2026 24w ago | Press Release | $3.59 $4.16 | ▲ +15.88% | ▲ +10.06% | — |
Apr 1, 2026 26w ago | EFFECT | $3.53 $3.31 | ▼ −6.23% | ▼ −15.95% | — |
Mar 27, 2026 27w ago | S-3/A | $3.73 $3.22 | ▼ −13.67% | ▼ −26.41% | — |
Mar 25, 2026 27w ago | S-3 | $3.77 $3.22 | ▼ −14.59% | ▼ −25.25% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access